cp wire

CP Wire Articles

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) announced on 9/10/18 publication of additional data from a Phase 2 single center, double-blind, placebo-controlled study to examine the safety and... read more

Mon, 09/10/18 - 09:53 am
admin
  • One analyst predicts peak revenue of 1.1billion in 2025
  • Over 1.1 million lidocaine patches sold in the US in 2017


Sorrento Therapeutics, Inc. (NASDAQ: SRNE) (“... read more

Mon, 09/10/18 - 09:13 am
admin
  • CABOMETYX is the only preferred tyrosine kinase inhibitor (TKI) treatment option for first-line patients in the poor- and intermediate-risk groups (Category 2A)
  • CABOMETYX is a... read more
Fri, 09/7/18 - 09:44 am
admin

Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect and restore the health of patients, today... read more

Thu, 09/6/18 - 12:16 pm
admin

Synlogic, Inc., (Nasdaq:SYBX) a clinical stage company applying synthetic biology to probiotics to develop novel, living medicines, today announced positive interim clinical data from the healthy... read more

Thu, 09/6/18 - 12:03 pm
admin
  • Allogene completed a $300 Million Series A round in April of 2018
  • Investors in the Series A round included Gilead and Pfizer


Allogene Therapeutics, Inc., a clinical-... read more

Thu, 09/6/18 - 09:37 am
admin
  • VX-659 and VX-445 are next gen correctors
  • Correctors fix the defective CFTR protein so that it can move to the proper place on the cell surface
  • Vertex expects to submit an... read more
Thu, 09/6/18 - 09:20 am
admin

Historical patent and exclusivity data for FDA-approved drugs now available

Hillsborough, New Jersey – September 5, 2018 – Bruce Pokras’ ... read more

Wed, 09/5/18 - 01:34 pm
admin
  • Lenvima is the first new systemic therapy approved for the first-line treatment of unresectable HCC in China in ten years
  • In China, there are approximately 395,000 new cases of liver... read more
Wed, 09/5/18 - 09:24 am
admin

EpicGenetics announced on9/5/18 that the U.S. Food and Drug Administration (FDA) has given approval to the Massachusetts General Hospital for a human clinical trial of BCG (an inexpensive generic... read more

Wed, 09/5/18 - 09:08 am
admin

Seres Therapeutics, Inc. (Nasdaq:MCRB) today announced the appointment of Meryl Zausner, a seasoned biopharmaceutical executive, to its Board of Directors. Ms. Zausner brings decades of financial... read more

Tue, 09/4/18 - 10:02 am
admin

LEO Pharma and Bayer announced today the completion of the relevant closing conditions to allow the transfer of Bayer’s prescription dermatology business to LEO Pharma in the United States.... read more

Tue, 09/4/18 - 09:55 am
admin

  • Many pathogens may inhibit or modulate their host’s immune system and thus circumvent immune defense
  • Immune system activating therapies may open transformative opportunities... read more
Tue, 09/4/18 - 09:44 am
admin

Macrolide Pharmaceuticals announced on 9/4/18 a leadership expansion that adds significant expertise in drug development, clinical strategy, finance and... read more

Tue, 09/4/18 - 09:28 am
admin


Sunovion Pharmaceuticals Inc. (Sunovion) announced on 8/31/18 that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter for the New Drug Application (NDA) for... read more

Fri, 08/31/18 - 10:42 am
admin


Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental Biologics License Application (sBLA) for Sprycel (dasatinib... read more

Thu, 08/30/18 - 09:44 am
CP Staff
  • Domagrozumab Ph II study did not meet primary endpoint
  • Pfizer is also developing a gene therapy, PF-06939926, for DMD
  • PF-06939926 has orphan status in the US and Europe... read more
Thu, 08/30/18 - 09:31 am
CP Staff
  • Onvansertib also has orphan status in the US
  • Onvansertib has the potential to improve clinical efficacy in Acute Myeloid Leukemia (AML), metastatic Castration-Resistant Prostate... read more
Wed, 08/29/18 - 12:24 pm
CP Staff
  • ATB-346 is a hydrogen sulfide-releasing derivative of naproxen
  • H2s has been shown to play important role in the maintenance of gastric mucosal integrity.


... read more

Wed, 08/29/18 - 09:57 am
CP Staff

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.